LIFNanoRx is awarded £1 million to prepare for first-in-man clinical trials.
Through the Government’s Innovation funding arm, “Innovate-UK”, LIFNanoRx has been awarded one million pounds from the BioMedical Catalyst Competition. The awarded Project has been designed by LIFNanoRx to ensure efficient progress in bringing the value of LIF to patients with MS.
The award – gained despite fierce competition – is evidence of the UK Government’s recognition of NanoMedicine. Furthermore, its recognition of LIFNanoRx as a strong commercial enterprise with the ability to bring their innovative therapy to treat MS on global scale.
Read the full article here.
Article Credit: LifNanoRx